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Abstract
Introduction: Spindle cell carcinoma (SpCC) is an unusual subtype of squamous cell carcinoma with an aggressive behavior. The
occurrence of this tumor in maxillary sinus has rarely been reported.
Case Presentation: This case report describes the diagnosis, management, and follow-up of a 35-year-old female, who presented
with Spindle cell carcinoma of maxillary sinus.
Conclusions: The behavior of maxillary sinus SpCC seems to be more aggressive than Spindle cell carcinoma of other sites and
shows a poor prognosis.
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1. Introduction
Spindle cell carcinoma is an unusual form of squa-
mous cell carcinoma that is specified by the World Health
Organization (WHO) as a biphasic tumor including ma-
lignant mesenchymal and epithelial elements. This can-
cer shows an aggressive behavior and a poor prognosis.
It is also known as pseudosarcoma, sarcomatoid carcino-
mas, and spindle or polypoid squamous cell carcinoma (1,
2). This tumor has been reported in various sites such as
esophagus, upper aerodigestive tract, lung, gastrointesti-
nal tract, breast, hepatobiliary system, and genitourinary
system. The subsites of head and neck consist of salivary
glands, pharynx, thyroid, larynx, thymus, oral cavity, and
nasal area (2-4). Most of the cases are present in male pa-
tients between the 6th and 8th decade of life, with a clinical
record associated with alcohol abuse, smoking, and radia-
tion exposure (5).
2. Case Presentation
2.1. Clinical History
A 35-year-old female was referred to Alzahra Hospital,
Isfahan in June 2015 with chief complaint of dental abscess.
She had a painless swelling in the right side of maxilla that
was appeared since past 6 months, but it was recently ex-
tended rapidly to orbit and nose. The medical history of
the patient was unremarkable. The patient did not express
any history of trauma in the maxillofacial complex, sinus-
related disease, or use of alcohol and tobacco. An informed
consent was taken from the patient.
Clinical examination revealed a swelling in the right
side of her face from infraorbital to lower lip together
with decreased mouth opening without any regional lym-
phadenopathy. Intraoral examination revealed halitosis,
some teeth with deep decay, and polypoid mass, measur-
ing 48× 31× 25 mm, extending from the right lateral in-
cisor to the tuberosity with an ulcer in the center of le-
sion with the maximum dimension of 20 mm. The patient
did not express any history of tenderness, dysesthesia, or
paresthesia.
According to these clinical features, the primary clini-
cal differential diagnoses were found to be benign inflam-
matory lesions such as pyogenic granuloma, peripheral gi-
ant cell granuloma, a locally aggressive infectious process,
and a malignancy.
We also performed a CT scan on the patient. Her CT-
scan results indicated a large destructive lesion with irreg-
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ular margins that filled the right-side maxillary sinus, infil-
trated to nasal cavity, lateral and inferior wall of orbit, mas-
seter muscle, alveolar process, and internal region of low
attenuation corresponding to necrotic areas. However, no
lymph node and distant metastasis were detected (Figure
1).
Figure 1. A Large Destructive Lesion with Irregular Margins That Filled the Right-
Side Maxillary Sinus Infiltrated to Nasal Cavity, Lateral and Inferior Wall of Orbit,
Masseter Muscle as Well as Alveolar Process and Internal Region of Low Attenuation
Corresponding to Areas of Necrosis.
Taking the radiographic appearance into considera-
tion, our differential diagnoses included malignant ag-
gressive lesions such as squamous cell carcinoma, lym-
phoma, soft tissue tumor (e.g. fibrosarcoma), and malig-
nant tumors of minor salivary gland origin (e.g. mucoepi-
dermoid carcinoma).
2.2. Diagnosis
The patient was admitted for additional tests. The vi-
tal signs, hematologic parameters, chest radiography, and
bone scintigraphy were all normal and did not show any
evidence of other lesions. An incisional biopsy was also
performed from the oral aspect of the lesion.
Hematoxylin and eosin–stained sections showed the
proliferation of spindle cells in streaming and fascicular
patterns, sometimes demonstrating epithelioid appear-
ance with pleomorphism, hyperchromatism, and a lot of
mitoses (Figure 2). According to these patterns, fibrosar-
coma, leiomyosarcoma, melanoma, and carcinosarcoma
were included in differentiated diagnosis and required im-
munohistochemical staining for CK, P63, EMA, S100, vi-
mentin Ki67, CD99, Desmin, and Melan A.
Immunohistochemical staining of tumor cells showed
focal positivity for CK and EMA, strong positivity for vi-
mentin, 15% to 20% positivity for Ki67, and negativity for
Figure 2. Spindle Cells in Streaming and Fascicular Pattern that Sometimes Demon-
strated Epitheloid Appearance, Pleomorphism, Hyperchromatism, and a Lot of Mi-
toses (400 x).
other markers. According to immunohistochemical find-
ings, the lesion was diagnosed as spindle cell carcinoma.
2.3. Management
The patient was treated with a surgical process, consist-
ing of right partial maxillectomy. Post-operatively, the pa-
tient underwent radiotherapy and chemotherapy on De-
cember 4th, 2015. There, she received 3-dimensional con-
formal radiotherapy (3-DCRT) and concurrent chemother-
apy. The prescribed dose of radiotherapy was 68 Gy/30
fraction at 2GY/fraction, 5 fractions in 1 week. The area
of radiotherapy included the tumor area, the right-side
maxillary sinus, and chemotherapy treatment consisting
of 50 mg/week cisplatin. After 5 months of primary
treatment, the patient revealed recurrent tumor and pul-
monary metastasis. She succumbed to the disease 12
months after the first diagnosis.
3. Discussion
Spindle cell carcinoma or sarcomatoid carcinoma is a
rare carcinoma that can occur in many parts of the body
such as the digestive and respiratory tract, breast, and kid-
ney. Most sarcomatoid carcinomas in hollow viscus are
polypoid and pedunculated (6, 7). The occurrence of this
tumor in nasal cavity and paranasal sinus is rare (8), with
only 15 cases reported in the English literature (4, 8, 9). The
reported cases indicated male predilection with the age
ranging from the third to seventh decade. Although to-
bacco, alcohol abuse, and previous irradiation have been
considered as predisposing factors (3, 4), in our case, no
habits were present. Some studies have reported that the
spindle cell element of sarcomatoid carcinoma is a sign of
metaplastic changes of the epithelial cells. This explana-
tion has been supported by ultrastructural and histpatho-
logic examinations (9, 10). Nappi et al. (11) indicated that
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epitheloid cell component is positive for keratin and neg-
ative for vimentin, while the spindle cell component is
reactive for vimentin but nonreactive for keratin. We re-
ported similar results except that the spindle cell compo-
nent showed focal positivity for EMA and keratin, reflect-
ing that the origin of these sacomatoid cells is epithelial
carcinoma cells with true mesenchymal metaplasia.
There is a controversy about the management of spin-
dle cell carcinoma due to the scarcity, difficulty of histo-
logical confirmation, and a shortage of literature about
disease pathogenesis, outcome survey, and management
guidelines (1, 3, 12).
Surgery seems to be the first option for primary and re-
current spindle cell carcinoma, where complete en bloc re-
section with larger safety border is needed. Either radio-
therapy or chemotherapy is an alternative option for in-
operable patients or those with sinonasal tumors. Over-
all, the time of diagnosis and the site of lesion affect the
outcome so that early stage diagnosis and extraoral le-
sion have been resulted in better outcomes (12-14)). Some
studies reported the increased mortality rate in the tu-
mors of the head and neck area as a result of lower resis-
tance to tumor-spreading along tissue planes and exten-
sive lymph drainage system with resultant lymphatic and
distant metastases (3, 4, 13).
Ellis et al. (15) reported a 36% survival rate in the pa-
tients with oral spindle cell carcinoma. Olsen et al. (16) re-
ported 34 cases with laryngeal and hypopharyngeal spin-
dle cell carcinoma; recurrence occurred in 10 cases and
the 3-year survival rate was 56.8%. In Su et al.’s (17) series,
the overall survival rate of oral spindle cell carcinoma was
27.5% over 3 years. The survival rate in our case was 12
months, which might be due to its late-stage patient.
4. Conclusions
It is necessary to expand the panel of immunohisto-
chemistry staining for precise diagnosis of SpCC. In max-
illary sinus, it shows rapidly growing with aggressive be-
havior and poor prognosis.
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